Converging with prices among white women and closing a gap that had existed for decades.

In 2012, overall breast cancer incidence prices converged between blacks and whites because of increasing incidence prices in black females and stable prices in white women. Notably, rates had been higher in blacks than whites in seven claims . As the good reason for increasing incidence in African American women is not clear, the authors note that the upsurge in incidence provides been driven by increases in ER positive breast cancers and may reflect rising rates of obesity. Mortality rates stayed higher in black women than in white ladies, despite historically lower incidence rates among black women.We are pleased to be chosen because of this mission-essential contribution, stated Rene Schena, CEO of Arrayit. This demonstrates the flexibility and durability of our microarray approach to identifying organics at the molecular level. Back on planet Earth, Arrayit’s microarray technology is being used in the discovery of the reactions within cells that lead to specific diseases. This revolution in health care will, in turn, lead to quick diagnostics and early recognition of cancers and auto-immune disease.

Biogen Idec, UCB indication agreements to commercialize treatment of hemophilia and MS in Asia Biogen Idec and UCB announced today they have signed special agreements granting UCB the proper to commercialize Biogen Idec items in South Korea, Hong Kong, Thailand, Singapore, Taiwan and Malaysia, and both develop and commercialize items in China.